Clinical Trial

Virtual Reality for Children in Radiotherapy (REVER)

Study acronym: REVER
Recruiting
View on ClinicalTrials.gov →
Summary
For a young patient, the conditions of proton therapy treatment can be stressful. Adjusting the environment can be a source of avoiding this physical and psychological discomfort impacting the quality of treatment. A fixed, long, uncomfortable position is the main cause of stress, already present due to the cancerous therapeutic course. It extends the positioning time. For the patient and the optimization of his treatment, solutions must be sought. Relaxation in virtual reality is efficient, simple and non-medicinal and could reduce stress in children and allow irradiation in very good conditions. We will assess the effectiveness of the virtual reality session using objective (placement time, helmet tolerance) and subjective (perceived anxiety via a dedicated questionnaire) criteria. This is the first pediatric virtual reality study, supported by the French Group of Pediatric Radiotherapists, to reduce anxiety in radiotherapy. Multiple benefits from this pilot study are expected, such as improved reception conditions, treatment parameters and better acceptance of proton therapy sessions.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-06-18; most recent amendment 2026-05-27.
Status change: Not Yet Recruiting → Recruiting 2021-10-25
Trial Details
NCT Number NCT04934293
Lead Sponsor Centre Antoine Lacassagne
Conditions Virtual Reality, Proton Therapy, Pediatric Cancer
Enrollment 47 participants
Start Date 2021-08-02
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-29